Marc Michel

20.4k citations
362 papers · 14.8k · 7 hit papers · h-index 63

Impact in

  • Hematology top 0.05%
    • Platelet Disorders and Treatments
    • Blood groups and transfusion
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Blood disorders and treatments

Papers in

    • Blood groups and transfusion 151
    • Platelet Disorders and Treatments 144
    • Chronic Lymphocytic Leukemia Research 35
    • Blood disorders and treatments 32

Marc Michel

327 papers receiving 14.3k citations

Marc Michel's Hit Papers

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database 2022 · 127 citations
1270+6+12Years since publication50010001.5k2.0k

Peers

Marc Michel
Comparison fields: 5 of 168
  • Hematology 8.4k
  • Genetics 2.1k
  • Immunology 2.2k
  • Infectious Diseases 1.9k
  • Pathology and Forensic Medicine 1.5k
Replace Bertrand Godeau with:
Bertrand Godeau France
Edward W. Cowen United States
Régis Peffault de Latour France
Jeff Szer Australia
Christina Peters Austria
Enric Carreras Spain
Victor S. Blanchette Canada
Keith M. Sullivan United States
Emanuele Angelucci Italy
Hildegard Greinix Austria
Marc Michel relative to Bertrand Godeau France Bertrand Godeau's profile →
Citations per field
00.5×1.5×1.8×
Bertrand Godeau · 1×
Citations per year

Countries citing papers authored by Marc Michel

Since Specialization
Citations

This map shows the geographic impact of Marc Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Michel more than expected).

Fields of papers citing papers by Marc Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Michel. The network helps show where Marc Michel may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Michel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Michel Line = papers co-authored together Marc Michel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 362 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Hit paper breakdown →
20082121
2
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Hit paper breakdown →
2019757
3
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Hit paper breakdown →
2020589
4
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Hit paper breakdown →
2019361
5 2020334
6
Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
Hit paper breakdown →
2021307
7 2021249
8 2020235
9 2018229
10
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Hit paper breakdown →
2021229
11 2021214
12 2008202
13 2009195
14 2013187
15
Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease.
2003181
16 2015170
17 2012167
18 2020167
19 2021162
20
Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.
2005154

About Marc Michel

Marc Michel is a scholar working on Hematology, Genetics, Nephrology, Immunology and Physiology, having authored 362 papers that have together received 14.8k indexed citations. Recurring topics across this work include Blood groups and transfusion (151 papers), Platelet Disorders and Treatments (144 papers), Erythrocyte Function and Pathophysiology (43 papers), Chronic Lymphocytic Leukemia Research (35 papers), Blood disorders and treatments (32 papers), Autoimmune Bullous Skin Diseases (28 papers), Renal Diseases and Glomerulopathies (27 papers) and Immunodeficiency and Autoimmune Disorders (23 papers). The work is most often cited by research in Hematology (8.4k citations), Genetics (2.1k citations), Immunology (2.2k citations), Infectious Diseases (1.9k citations) and Pathology and Forensic Medicine (1.5k citations). Marc Michel has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Bertrand Godeau, James Bruce Bussel, Philippe Bierling, Mehdi Khellaf, Nichola Cooper, Donald M. Arnold, Terry Gernsheimer, Douglas B. Cines, Francesco Rodeghiero and Roberto Stasi. Their work appears in journals such as Blood, American Journal of Hematology, British Journal of Haematology, HemaSphere and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact